Wegovy
Avalible to order
Medication Features
Alternative to Mounjaro
1 Pen = 4 weekly doses, lasting for a month
Once-weekly Semaglutide weight loss injection
Up to 20.7% Average Weight Loss*
* Combine it with regular physical activity and a well-maintained diet for best results.
Reviewed By: Mr A Salih
GPhC Registration: 2212755
Last reviewed on: 15/12/2025
Wegovy is a once-weekly Semaglutide weight loss injection and the recommended first-line treatment option for weight loss by the medical experts at Cadogan Weight Loss Clinic. It contains the same active ingredient as Ozempic – Semaglutide.
Each pack of Wegovycontains 4 x weekly doses.
Prices include prescription
0.25 mg(4 x doses of 0.25 mg) £139.00
0.5 mg(4 x doses of 0.5 mg) £179.00
1 mg(4 x doses of 1 mg) £187.00
1.7 mg(4 x doses of 1.7 mg) £237.00
2.4 mg(4 x doses of 2.4 mg) £287.00
Start the consultation to proceed:
You will be able to select a suitable treatment after you have completed the consultation form.
Buy Wegovy Weight Loss Injection In the UK
Access genuine Wegovy injections through our regulated UK online clinic. Our expert pharmacists and prescribers provide safe, convenient access to this clinically-proven weight loss treatment with fast, discreet delivery across the UK.
What is Wegovy?
Wegovy (semaglutide) is a clinically-proven prescription medication for weight management in adults with obesity or excess weight alongside weight-related health conditions.
It's administered as a once-weekly subcutaneous injection and has been clinically proven to help patients achieve and maintain significant weight loss when combined with a reduced-calorie diet and increased physical activity.
How Wegovy Works
Wegovy injections work by mimicking the GLP-1 (glucagon-like peptide-1) hormone your body naturally produces. This hormone targets areas involved in regulating appetite and blood sugar, helping you eat fewer calories and lose weight.
Wegovy is most effective when used alongside a balanced, healthy diet and increased physical activity.
Minimises Cravings
Wegovy can reduce food cravings (food noise) for high-fat foods, helping you eat a lower-calorie diet with less effort.
Reduces Appetite
By acting on areas of the brain that control hunger, Wegovy helps you feel satisfied with smaller portions.
Slows Gastric Emptying
Wegovy slows the rate at which food leaves your stomach, helping you feel fuller for longer periods.
Supports Blood Sugar Regulation
Helps maintain stable blood sugar levels, reducing energy crashes and appetite spikes.
See Your Potential Results
Calculate your BMI and discover what up to 20.7% weight loss could mean for you with Wegovy.
Check your eligibility in seconds
See your potential weight loss journey
Understand your BMI category
What does 20.7% weight loss look like for you?
Calculate your BMI to see where your weight journey could take you with Wegovy
Simple Process
How to get started
1
3
2
Start Your Assessment
Get Your Recommendation
Confirm & Receive
Complete a short health check with our UK-registered clinicians.
Choose the treatment suggested after your consultation.
Receive your prescription safely via tracked delivery.
Already on Mounjaro? Switch with Confidence
Seamlessly transition to Wegovy. Our commitment to your journey.
1
Switch to an Equivalent Dose
Switch to Wegovy at an equivalent dose to your current Mounjaro treatment. No need to restart your progress.
2
Immediate Adjustment Support
Get personalized side effect guidance included with your first order, and connect with our prescribers if needed.
3
Continue and Save
Stay on track with competitive pricing to help you reach your goal weight.
Transform Today, Protect Tomorrow
Our medically-supervised weight loss programmes are backed by clinical research and designed to help you achieve lasting results without extreme lifestyle changes.
Guided by Science
Our treatment plans are backed by clinical trials and proven to help you achieve weight loss without extreme dietary restriction.
Supported by Your Team
Work with your dedicated healthcare team who prioritise your needs—from medication management to addressing lifestyle factors.
Built to Last
We don't just help you lose weight. We help you develop sustainable habits that last well beyond the treatment.
Who It's For
Mounjaro may be suitable for adults with:
BMI of 30 or greater (obesity), or
BMI of 27 or greater with at least one weight-related condition (e.g., type 2 diabetes, high blood pressure)
Dose Escalation Schedule
Wegovy follows a gradual dose escalation protocol to minimize side effects and optimize tolerance:
0.25 mg
Weeks 1-4
0.5 mg
Weeks 5-8
1.0 mg
Weeks 9-12
1.7 mg
Weeks 13-16
2.4mg
Weeks 17+
How to Use Your Wegovy FlexTouch Pen
Mounjaro comes in an easy-to-use pre-filled KwikPen. Each pen contains 4 weekly doses (0.6ml per injection).
1
Prepare Your Pen
Attach a new needle and prime the pen before first use
2
Choose Injection Site
Stomach, thigh, or back of upper arm. Rotate sites weekly
3
Inject & Dispose
Select dose, inject, hold for 6 seconds. Dispose safely
Side Effects & Safety
Frequently Asked Questions
Authored on December 3, 2025
Mr A Salih - MRPharmS
Lead Prescribing Pharmacist
GPhC Number: 2212755
Reviewed on December 3, 2025
Clinical Team
Clinical Pharmacist / Medical Review
UK-Registered Healthcare Professional
Refrences
1. Ghusn W, De la Rosa A, Sacoto D, Cifuentes L, Campos A, Feris F, et al. Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity. JAMA Network Open [Internet]. 2022;5(9):e2231982. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486455/. Retrieved December 3, 2025.
2. Wilding JPH, Batterham RL, Calanna S. Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine [Internet]. 2021 Feb 10;384(11):989–1002. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2032183. Retrieved December 3, 2025.
3. Moiz A, Levett JY, Filion KB, Peri K, Reynier P, Eisenberg MJ. Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. The American Journal of Cardiology [Internet]. 2024 Apr 26;222:121–30. Available from: https://pubmed.ncbi.nlm.nih.gov/38679221. Retrieved December 3, 2025.
4. Garvey WT, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, et al. Two-year effects of semaglutide in adults with overweight or obesity: The STEP 5 trial. Nature Medicine. 2022 Oct 1;28(10):2083–91. Available from: https://www.nature.com/articles/s41591-022-02026-4. Retrieved December 3, 2025.
5. Wegovy 1 mg, FlexTouch solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). Available from: https://www.medicines.org.uk/emc/product/13801/smpc. Retrieved December 3, 2025.
Last medically reviewed: December 3, 2025